Skip to main content
Loading market data...

Compare ETFs

Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.

Two to four symbols separated by commas. ASX funds end in .AX, for example A200.AX.
General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Side by side

Comparison of GDOC, CGDV
Measure GDOCGoldman Sachs Future Health Care Equity ETF CGDVCapital Group Dividend Value ETF
MarketUSNYSE ArcaUSNYSE Arca
IssuerGoldman SachsCapital Group
Asset classEquity · GlobalEquity · Global
Expense ratio0.75%Expense ratio, filed 29 Dec 20250.33%Expense ratio, filed 7 Aug 2025
Net assets$20.1MAs of 31 May 2026 $35.2BAs of 31 May 2026
Holdings42As of 31 May 2026 53As of 31 May 2026
12-month distribution yield0.31%0.92%
DistributionsYearly$0.1130 in 12 months Quarterly$0.4500 in 12 months
Last price$36.8820 Oct 2026, 13:46 UTC$49.1720 Oct 2026, 20:00 UTC

Holdings overlap

Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.

Weighted holdings overlap between each pair of funds
FundGDOCCGDV
GDOC Same fund 5.3%
CGDV 5.3% Same fund

GDOC and CGDV

Weighted overlap
5.3%
Of each fund's net assets
Holdings in common
3
41 in GDOC, 53 in CGDV
GDOC holdings also in CGDV
7.3% by count
16.1% of GDOC by weight
CGDV holdings also in GDOC
5.7% by count
6.0% of CGDV by weight

Common holdings matched: 3 by ISIN, 0 by CUSIP and 0 by issuer name. Holdings as of 31 May 2026 (GDOC) and 31 May 2026 (CGDV).

Largest positions held by both GDOC and CGDV
HoldingWeight in GDOCWeight in CGDVOverlapMatched by
ELI LILLY & COMPANYELI LILLY & COMPANY COM US5324571083 13.28% 3.15% 3.15% ISIN
UNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INC COM US91324P1021 1.35% 2.02% 1.35% ISIN
VERTEX PHARMACEUTICALS INCVERTEX PHARMACEUTICALS INC COM US92532F1003 1.48% 0.80% 0.80% ISIN
How overlap is measured

Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.

Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.

Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.

The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.

Currency exposure

Weight of holdings denominated in each currency
CurrencyGDOCCGDV
US dollar (USD) 87.1% 96.0%
British pound (GBP) 4.8% 2.7%
Swiss franc (CHF) 3.9% Below the top 12 or none
Japanese yen (JPY) 3.5% Below the top 12 or none
Canadian dollar (CAD) Below the top 12 or none 1.3%
Euro (EUR) 0.6% Below the top 12 or none
IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme